Aquilo Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-138,521
| Closed | -$3.79M | – | 9 |
|
|
2025
Q1 | $3.79M | Sell |
138,521
-45,000
| -25% | -$1.23M | 6.8% | 4 |
|
|
2024
Q4 | $7.38M | Sell |
183,521
-25,222
| -12% | -$1.01M | 11.13% | 3 |
|
|
2024
Q3 | $9.88M | Sell |
208,743
-120,000
| -37% | -$5.68M | 7.49% | 3 |
|
|
2024
Q2 | $9.81M | Sell |
328,743
-60,000
| -15% | -$1.79M | 9.46% | 5 |
|
|
2024
Q1 | $15.6M | Sell |
388,743
-492,594
| -56% | -$19.8M | 11.71% | 5 |
|
|
2023
Q4 | $22.4M | Buy |
881,337
+99,118
| +13% | +$2.52M | 13.98% | 3 |
|
|
2023
Q3 | $10.9M | Buy |
782,219
+130,894
| +20% | +$1.82M | 9.85% | 5 |
|
|
2023
Q2 | $15M | Buy |
651,325
+50,000
| +8% | +$1.15M | 8.3% | 6 |
|
|
2023
Q1 | $17.8M | Sell |
601,325
-28,086
| -4% | -$832K | 7.38% | 4 |
|
|
2022
Q4 | $15.7M | Buy |
629,411
+299,165
| +91% | +$7.47M | 5.9% | 7 |
|
|
2022
Q3 | $7.19M | Buy |
+330,246
| New | +$7.19M | 2.59% | 11 |
|